ARCHIVES

MDV3100 Improves Survival, Reduces Death Risk by 37%

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977

NCI Is Considering New Core Grants For Prostate, Breast Research Centers

April 19, 1991

“We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board

January 1, 1993

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994